Beta Interferon Dramatic Covid Improvement

In this video, Dr. John Campbell reports on the great success with bera interferon in treating Chinese Wuhan Covid. Something like a 79% success rate in eliminating severe symptoms.

Most intriguing is the statement that covid blocks our cells natural production….

Subscribe to feed

About E.M.Smith

A technical managerial sort interested in things from Stonehenge to computer science. My present "hot buttons' are the mythology of Climate Change and ancient metrology; but things change...
This entry was posted in Covid and tagged , , , . Bookmark the permalink.

3 Responses to Beta Interferon Dramatic Covid Improvement

  1. cdquarles says:

    Yeah, I have run across a few papers talking about an HIV-like ability to subvert cellular immunity. Some claim that was from human manipulation. Maybe, but not necessarily. One of the things viruses do is exchange nucleic acids and for zoonotic ones, across species. Plus, there is no chemical that man can make that the rest of nature can’t; and vice-versa.

  2. erl happ says:

    Pity he seems to be ignorant of the efficacy of Ivermectin.

  3. E.M.Smith says:

    He has covered Ivermectin, but said while very promising the clinical trials aren’t finished yet (IIRC). He’s adverse to endorsing anything not trialed and published. So I take the claim of “best we’ve got” to more accuratly mean “best we’ve got currently approved for use in hospital in the UK after published trials completed”.

    But yeah, I’m very glad my bunny ivermectin was arround…

Anything to say?

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.